Advanced search
Start date
Betweenand


Water-Soluble Well-Defined Bifunctional Ferrocenyl Dendrimer with Anti-Cancer Activity

Full text
Author(s):
Bertuzzi, Diego L. ; Braga, Carolyne B. ; Perli, Gabriel ; Ornelas, Catia
Total Authors: 4
Document type: Journal article
Source: European Journal of Inorganic Chemistry; v. 2022, n. 9, p. 6-pg., 2022-02-01.
Abstract

Combination of advantages of ferrocenyl compounds and multifunctional dendrimer scaffold afforded a water-soluble well-defined bifunctional dendrimer with polyamide backbone and thirty two termini: eighteen carboxylic acid groups and eighteen triazolylferrocenyl moieties. The structure of the new dendrimer was thoroughly characterized by nuclear magnetic resonance (NMR) spectroscopy, absorbance spectroscopy in the UV-vis, and MALDI-TOF mass spectrometry. The MALDI-TOF spectrum of the final dendrimer showed the [M](2+) ion peak at 4820.1 m/z unambiguously confirming the successful synthesis of the water-soluble well-defined bifunctional dendrimer. The cytotoxicity of the well-defined bifunctional triazolylferrocenyl dendrimer 4 was evaluated against MCF-7 (breast adenocarcinoma), HeLa (cervical cancer), PC3 (prostate adenocarcinoma), Caco-2 (colorectal cancer), and PNT2 (normal prostate cells) cell lines. The cytotoxicity assays showed that the dendrimer exhibits moderate anticancer activity and targets cancer cells selectively over normal cells. (AU)

FAPESP's process: 17/06146-8 - Development of nanocarriers based on dendrimers and polymer nanoparticles for selective delivery of goniothalamin, piplartine and Monastrol
Grantee:Carolyne Brustolin Braga
Support Opportunities: Scholarships in Brazil - Post-Doctoral
FAPESP's process: 15/04929-0 - Development of biosensors for instantaneous detection of proteins and cancer cells, for application on on-site biopsy
Grantee:Diego Luan Bertuzzi
Support Opportunities: Scholarships in Brazil - Doctorate (Direct)
FAPESP's process: 21/00555-9 - Development of polymeric nanoparticles and multifunctional dendrimers for drug delivery
Grantee:Igor Dias Jurberg
Support Opportunities: Regular Research Grants